Association of adiponectin gene polymorphism with nonalcoholic fatty liver disease in Taiwanese patients with type 2 diabetes

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Hsieh, Ching Jung ^a   Wang, Pei Wen ^a   Hu, Tsung Hui ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN;

ADIPONECTIN GENE; ADIPONUTRIN GENE; ADULT; ARTICLE; BODY FAT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPOADIPONECTINEMIA; LEPTIN GENE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA GENE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA GENE; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWANESE; ALLELE; ANTHROPOMETRY; BLOOD; COMPLICATION; DEMOGRAPHY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; TAIWAN;

ADIPONECTIN; ALLELES; ANTHROPOMETRY; DEMOGRAPHY; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; TAIWAN;

EID: 84934995567     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0127521     Document Type: Article

References (37)

1. Zhou YJ, Li YY, Nie YQ, Huang CM, Cao CY. Natural course of nonalcoholic fatty liver disease in southern China: a prospectivecohort study. J Dig Dis. 2012; 13: 153-160. doi: 10.1111/j.1751-2980.2011.00571.x PMID: 22356310
2. Souza MR, Diniz Mde F, Medeiros-Filho JE, Araújo MS. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arq Gastroenterol. 2012; 49: 89-96. PMID: 22481692
3. Hallsworth K, Hollingsworth KG, Thoma C, Jakovljevic D, MacGowan GA, Anstee QM, Tet al. Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease. J Hepatol. 2013; 58: 757-762. doi: 10.1016/j.jhep.2012.11.015 PMID: 23178979
4. Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH, et al. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan. J Gastroenterol Hepatol. 2007; 22: 1482-1489. PMID: 17716352
5. Amarapurkar D, Kamani P, Patel N, Gupte P, Kumar P, Agal S, et al. Prevalence of non-alcoholic fatty liver disease: population based study. Ann Hepatol. 2007; 6: 161-163. PMID: 17786142
6. Merat S, Yarahmadi S, Tahaghoghi S, Alizadeh Z, Sedighi N, Mansournia N, et al. Prevalence of Fatty Liver Disease among Type 2 Diabetes Mellitus Patients and its Relation to Insulin Resistance. Middle East Journal of Digestive Diseases. 2009; 1: 74-79.
7. Leite NC, Salles GF, Araujo AL, Villela-Nogueira CA, Cardoso CR. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus Liver Int. 2009; 29:113-119. doi: 10.1111/j.1478-3231.2008.01718.x PMID: 18384521
8. Tandon RK. Emergence of non-alcoholic fatty liver disease (NAFLD). J Assoc Physicians India. 2013; 61: 445-446. PMID: 24772745
9. Bonapace S, Perseghin G, Molon G, Canali G, Bertolini L, Zoppini G, et al. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. Diabetes Care 2012; 35: 389-395. doi: 10.2337/dc11-1820 PMID: 22210573
10. Bonapace S, Valbusa F, Bertolini L, Pichiri I, Mantovani A, Rossi A, et al. Nonalcoholic fatty liver disease is associated with aortic valve sclerosis in patients with type 2 diabetes mellitus. PLoS One. 2014 5; 9: e88371.
11. Adams LA, Lymp JF, Sauver J St, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005; 129: 113-121. PMID: 15628891
12. Li YY. Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease. World J Gastroenterol. 2012; 18: 6546-6551 doi: 10.3748/wjg.v18.i45.6546 PMID: 23236228
13. Lu H, Sun J, Sun L, Shu X, Xu Y, Xie D. Polymorphism of human leptin receptor gene is associated with type 2 diabetic patients complicated with non-alcoholic fatty liver disease in China. J Gastroenterol Hepatol. 2009; 24: 228-32
14. Zain SM, Mohamed Z, Mahadeva S, Cheah PL, Rampal S, Chin KF, et al. Impact of leptin receptor gene variants on risk of non-alcoholic fatty liver disease and its interaction with adiponutrin gene. J Gastroenterol Hepatol. 2013; 28: 873-879. doi: 10.1111/jgh.12104 PMID: 23278404
15. Yoneda M, Hotta K, Nozaki Y, Endo H, Uchiyama T, Mawatari H, et al. Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD) BMC Gastroenterol. 2008; 8:27 doi: 10.1186/1471-230X-8-27 PMID: 18588668
16. Chen S, Li Y, Li S, Yu C. A Val227Ala substitution in the peroxisome proliferator activated receptor alpha (PPAR alpha) gene associated with non-alcoholic fatty liver disease and decreased waist circumference and waist-to-hip ratio. J Gastroenterol Hepatol. 2008; 23: 1415-1418 doi: 10.1111/j.1440-1746.2008.05523.x PMID: 18853997
17. Hui Y, Yu-Yuan L, Yu-Qiang N, Wei-Hong S, Yan-Lei D, Xiao-Bo L, et al. Effect of peroxisome proliferator-activated receptors-gamma and co-activator-1alpha genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people. Liver Int. 2008; 28:385-392. PMID: 17999673
18. Lin YC, Chang PF, Chang MH, Ni YH.Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals. Am J Clin Nutr. 2014; 99: 869-874 doi: 10.3945/ajcn.113.079749 PMID: 24477042
19. Shen J, Wong GL, Chan HL, Chan HY, Yeung DK, Chan RS, et al. PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome. Aliment Pharmacol Ther. 2014; 39: 532-539. doi: 10.1111/apt.12609 PMID: 24417250
20. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology. 2003; 37: 1202-1219.
21. Ranjith N, Pegoraro RJ, Naidoo DP, Shanmugam R, Rom L. Genetic variants associated with insulin resistance and metabolic syndrome in young Asian Indians with myocardial infarction. Metab. Syndr. Relat. Disord. 2008; 6: 209-214. doi: 10.1089/met.2008.0023 PMID: 18710329
22. Shen F, Zheng RD, Mi YQ, Wang XY, Pan Q, Chen GY, et al. Controlled attenuation parameter for noninvasive assessment of hepatic steatosis in Chinese patients. World J Gastroenterol. 2014; 20: 4702-4711. doi: 10.3748/wjg.v20.i16.4702 PMID: 24782622
23. Wang ZL, Xia B, Shrestha U, Jiang L, Ma CW, Chen Q, et al. Correlation between adiponectin polymorphisms and non-alcoholic fatty liver disease with or without metabolic syndrome in Chinese population. Endocrinol Invest. 2008; 31: 1086-1091. PMID: 19246975
24. Tokushige K, Hashimoto E, Noto H, Yatsuji S, Taniai M, Torii N, et al. Influence of adiponectin gene polymorphisms in Japanese patients with non-alcoholic fatty liver disease. J Gastroenterol. 2009; 44: 976-982.
25. Zhou YJ, Li YY, Nie YQ, Yang H, Zhan Q, Huang J, et al. Influence of polygenetic polymorphisms on the susceptibility to non-alcoholic fatty liver disease of Chinese people. J Gastroenterol Hepatol. 2010; 25: 772-777.
26. Gupta AC, Misra R, Sakhuja P, Singh Y, Basir SF, Sarin SK. Association of adiponectin gene functional polymorphisms (-11377C/G and +45T/G) with nonalcoholic fatty liver disease. Gene. 2012; 496: 63-67. doi: 10.1016/j.gene.2011.12.023 PMID: 22269154
27. Musso G, Gambino R, De Michieli F, Durazzo M, Pagano G, Cassader M. Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH. Hepatology. 2008; 47: 1167-1177.
28. Meirhaeghe A, Cottel D, Amouyel P. Lack of association between certain candidate gene polymorphisms and the metabolic syndrome. Mol. Genet. Metab. 2005; 86: 293-299. PMID: 15978856
29. Hashemi M, Hanafi Bojd H, Eskandari Nasab E, Bahari A, Hashemzehi NA, Shafieipour S, et al. Association of Adiponectin rs1501299 and rs266729 Gene Polymorphisms With Nonalcoholic Fatty Liver Disease. Hepat Mon. 2013; 13: e9527 doi: 10.5812/hepatmon.9527 PMID: 23922565
30. Yu SY, Ryu HK, Park HJ, Choi YJ, Huh KB, Kim WY. Adiponectin gene SNP 276G → T, nutrient intakes, and cardiovascular disease risk in Korean type 2 DM patients. Nutr Res Pract. 2007; 1: 363-370. doi: 10.4162/nrp.2007.1.4.363 PMID: 20368963
31. Lu JF, Zhou Y, Huang GH, Jiang HX, Hu BL, Qin SY. Association of ADIPOQ polymorphisms with obesity risk: A meta-analysis. Hum Immunol. 2014; 75: 1062-1068. doi: 10.1016/j.humimm.2014.09.004 PMID: 25223469
32. Suriyaprom K, Phonrat B, Tungtrongchitr R. Association of adiponectin gene -11377C>G polymorphism with adiponectin levels and the metabolic syndrome in Thais. Asia Pac J Clin Nutr. 2014; 23: 167-173. doi: 10.6133/apjcn.2014.23.1.01 PMID: 24561985
33. Wang PW, Hsieh CJ, Psang LC, Cheng YF, Liou CW, Weng SW, et al, Fatty liver and chronic inflammation in Chinese adults. Diabetes Res Clin Pract. 2008 81: 202-208. doi: 10.1016/j.diabres.2008.04.014 PMID: 18534708
34. Hui E, Xu A, Bo Yang H, Lam KS. Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: Role of adipokines. J Diabetes Investig. 2013; 4: 413-425,
35. Bugianesi E, Pagotto U, Manini R, Vanni E, Gastaldelli A, de Iasio R et al. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab 2005; 90: 3498-3504. PMID: 15797948
36. Musso G, Gambino R, Durazzo M, Biroli G, Carello M, Fagà E, et al. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology 2005; 42: 1175-1183. PMID: 16231364
37. Tapper EB, Castera L, Afdhal NH. FibroScan (Vibration-Controlled Transient Elastography): Where Does It Stand in the United States Practice. Clin Gastroenterol Hepatol 2015; 13: 27-36. doi: 10.1016/j.cgh.2014.04.039 PMID: 24909907